Javier Fernández Fernández-rekin lankidetzan egindako argitalpenak (11)

2024

  1. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

    Human Genetics and Genomics Advances, Vol. 5, Núm. 4

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity

    FASEB Journal, Vol. 37, Núm. 11

2021

  1. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility

    PLoS ONE, Vol. 16, Núm. 8

2020

  1. Genomewide association study of severe covid-19 with respiratory failure

    New England Journal of Medicine, Vol. 383, Núm. 16, pp. 1522-1534

2016

  1. Analysis of HFE mutations and non-HFE gene mutations (TFR2 and SLC40A1) in patients with phenotypic hemochromatosis from the basque country

    International Journal of Laboratory Hematology

2012

  1. Is the role of liver biopsy changing in hemochromatosis? a non invasive approach is ready

    Journal of Gastrointestinal and Liver Diseases

2010

  1. Significance of H63D homozygosity in a Basque population with hemochromatosis

    Journal of Gastroenterology and Hepatology (Australia), Vol. 25, Núm. 7, pp. 1295-1298

2008

  1. Porfiria cutánea tarda: Asociación con mutaciones HFE, hepatitis virales, alcohol y otros factores de riesgo en Guipúzcoa, País Vasco

    Revista Espanola de Enfermedades Digestivas, Vol. 100, Núm. 12, pp. 774-778

  2. Utilidad de los diferentes métodos no invasivos de predicción de fibrosis hepática en pacientes del País Vasco con hemocromatosis fenotípica

    Revista Espanola de Enfermedades Digestivas, Vol. 100, Núm. 10, pp. 611-614